Skip to main content
Caplight Logo









Regenasome Pty Ltd

Regenasome Pty Ltd

Private
MelbourneHealthcare & Life Scienceshttps://regenasome.com

Last Round

Pre Seed

Sep 18, 2025

Total Funding Raised

$830,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Regenasome Pty Ltd is a biotechnology company that develops exosome-based therapies for the treatment of fibrotic and lung diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Space Technology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

exosome therapyregenerative medicineanti-aginglongevity researchexosome analysisnutraceuticalsbiotechnologybiohackinghealthspan extensionfunctional foodsspace medicinecosmeceuticalsprecision medicineclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Regenasome Pty Ltd Comparables

Compare Regenasome Pty Ltd with similar companies based on industry and business-model similarity.

Regenasome Pty Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ExoCoBio
72%
VivaZome Therapeutics
61%
Aegle Therapeutics Corp
55%

Regenasome Pty Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 18, 2025
DebtMay 1, 2025
Pre SeedOct 22, 2024

Regenasome Pty Ltd Investors

Notable investors and investment history

Regenasome Pty Ltd investors
InvestorRounds
Leave a Nest CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 18, 2025

    $130K round led by Leave a Nest Capital

Regenasome Pty Ltd Filings

Explore SEC and related filing metadata, where available.

Regenasome Pty Ltd filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Regenasome Pty Ltd's valuation, stock price, and market status.

Is Regenasome Pty Ltd a public or private company?

Regenasome Pty Ltd is a private company.

What is the current stock price of Regenasome Pty Ltd?

Regenasome Pty Ltd is a private company with no public stock price. No recent secondary market data is available.

How much is Regenasome Pty Ltd worth (valuation)?

Valuation information for Regenasome Pty Ltd is not publicly available.

Can I buy Regenasome Pty Ltd stock?

Regenasome Pty Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Regenasome Pty Ltd's last funding round?

Regenasome Pty Ltd's most recent funding round was Pre Seed on September 18, 2025.

Who are the main investors in Regenasome Pty Ltd?

Key investors in Regenasome Pty Ltd include Leave a Nest Capital.

Will Regenasome Pty Ltd IPO soon?

No public IPO plans have been announced for Regenasome Pty Ltd.

How can I track Regenasome Pty Ltd secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Regenasome Pty Ltd's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMelbourne
Year Founded2018
Last FundingSep 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?